Jiaping Zheng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Oxidative Stress

Cell Proliferation

Long Non Coding Rna

Top Venues

Clinical Medicine Insights. Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Fei Cao, Weiyuan Hao, Weiren Liang, Hui Zeng, Jiaping Zheng
MiR-339-5p Inhibits Ferroptosis by Promoting Autophagic Degradation of FTH1 Through Targeting ATG7 in Liver Cancer Cells. Clinical Medicine Insights. Oncology 18 (2024)
Fei Cao, Weiyuan Hao, Weiren Liang, Hui Zeng, Jiaping Zheng
MiR-339-5p Inhibits Ferroptosis by Promoting Autophagic Degradation of FTH1 Through Targeting ATG7 in Liver Cancer Cells. Clinical Medicine Insights. Oncology 18 (2024)
Fei Cao, Weiyuan Hao, Weiren Liang, Hui Zeng, Jiaping Zheng
MiR-339-5p Inhibits Ferroptosis by Promoting Autophagic Degradation of FTH1 Through Targeting ATG7 in Liver Cancer Cells. Clinical Medicine Insights. Oncology 18 (2024)